These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 2851364

  • 1. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R, Willems R, De Prins E, Wauquier A.
    Brain Res; 1988 Aug 09; 457(2):226-40. PubMed ID: 2851364
    [Abstract] [Full Text] [Related]

  • 2. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD.
    Eur J Pharmacol; 1989 Aug 11; 167(1):127-35. PubMed ID: 2550253
    [Abstract] [Full Text] [Related]

  • 3. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC, Wong EH.
    Br J Pharmacol; 1987 Jun 11; 91(2):403-9. PubMed ID: 2886170
    [Abstract] [Full Text] [Related]

  • 4. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL.
    Proc Natl Acad Sci U S A; 1986 Sep 11; 83(18):7104-8. PubMed ID: 3529096
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME, Arnolde SM.
    Brain Res; 1989 Nov 27; 503(1):1-4. PubMed ID: 2558775
    [Abstract] [Full Text] [Related]

  • 6. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME.
    Brain Res; 1988 Oct 25; 463(1):90-9. PubMed ID: 2848609
    [Abstract] [Full Text] [Related]

  • 7. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W, Woods JH, Winger GD.
    J Pharmacol Exp Ther; 1988 Jun 25; 245(3):969-74. PubMed ID: 2838610
    [Abstract] [Full Text] [Related]

  • 8. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression.
    Lauritzen M, Hansen AJ.
    J Cereb Blood Flow Metab; 1992 Mar 25; 12(2):223-9. PubMed ID: 1312539
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of synaptic versus non-synaptic epileptogenesis by NMDA antagonists in the in vitro hippocampus.
    Ashton D, Willems R, De Prins E, Wauquier A.
    Epilepsy Res; 1988 Mar 25; 2(3):219-22. PubMed ID: 2848699
    [Abstract] [Full Text] [Related]

  • 10. Effects of antagonists on N-methyl-D-aspartate response in acutely isolated nucleus tractus solitarii neurons of the rat.
    Nakagawa T, Shirasaki T, Tateishi N, Murase K, Akaike N.
    Neurosci Lett; 1990 May 31; 113(2):169-74. PubMed ID: 1974040
    [Abstract] [Full Text] [Related]

  • 11. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats.
    Tang AH, Ho PM.
    Eur J Pharmacol; 1988 Jun 22; 151(1):143-6. PubMed ID: 3046954
    [Abstract] [Full Text] [Related]

  • 12. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
    Nellgård B, Wieloch T.
    Acta Physiol Scand; 1992 Dec 22; 146(4):497-503. PubMed ID: 1283483
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.
    Obrenovitch TP, Zilkha E.
    Br J Pharmacol; 1996 Mar 22; 117(5):931-7. PubMed ID: 8851513
    [Abstract] [Full Text] [Related]

  • 14. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
    Daniell LC.
    Pharmacol Biochem Behav; 1990 May 22; 36(1):111-5. PubMed ID: 2190239
    [Abstract] [Full Text] [Related]

  • 15. Effects of N-methyl-D-aspartate antagonists on the cough reflex.
    Kamei J, Tanihara H, Igarashi H, Kasuya Y.
    Eur J Pharmacol; 1989 Sep 13; 168(2):153-8. PubMed ID: 2691260
    [Abstract] [Full Text] [Related]

  • 16. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W, Hönack D.
    J Pharmacol Exp Ther; 1991 Feb 13; 256(2):432-40. PubMed ID: 1671593
    [Abstract] [Full Text] [Related]

  • 17. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
    France CP, Woods JH, Ornstein P.
    Eur J Pharmacol; 1989 Jan 10; 159(2):133-9. PubMed ID: 2651134
    [Abstract] [Full Text] [Related]

  • 18. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ, Rose IC.
    Psychopharmacology (Berl); 1989 Jan 10; 99(1):87-90. PubMed ID: 2550989
    [Abstract] [Full Text] [Related]

  • 19. Modulation of release of acetylcholine from the striatum by a proposed excitatory amino acid antagonist U-54494A: comparison with known antagonists, diazepam and phenytoin.
    Sethy VH, Sage GP.
    Neuropharmacology; 1992 Feb 10; 31(2):111-4. PubMed ID: 1348110
    [Abstract] [Full Text] [Related]

  • 20. NMDA receptor antagonists can enhance or impair learning performance in animals.
    Mondadori C, Weiskrantz L, Buerki H, Petschke F, Fagg GE.
    Exp Brain Res; 1989 Feb 10; 75(3):449-56. PubMed ID: 2545467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.